220 related articles for article (PubMed ID: 16753758)
1. Favourable outcome of pulmonary zygomycosis in haematological malignancy.
Opeskin K; Sheorey H; Wright G; Nandurkar H
Pathology; 2006 Jun; 38(3):271-3. PubMed ID: 16753758
[No Abstract] [Full Text] [Related]
2. Challenges in the management of invasive pulmonary zygomycosis: the Alfred experience.
Saxena P; Shen SH; Morrissey O; Gooi JH
ANZ J Surg; 2015 Oct; 85(10):700-1. PubMed ID: 26429509
[No Abstract] [Full Text] [Related]
3. Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient.
Crompton JA; Alexander D; Somerville T; Shihab FS
Transpl Infect Dis; 2004 Dec; 6(4):183-7. PubMed ID: 15762937
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole.
Cooke DT; Pagani FD; Kaul DR; Cooke KR; Lau CL; Riddell J
Mycoses; 2010 Mar; 53(2):163-7. PubMed ID: 19207843
[No Abstract] [Full Text] [Related]
5. Surgical resection and liposomal amphotericin B to treat cavitary pulmonary zygomycosis in a patient with diabetes.
Hua-Ping Z; Jian L; Jing-Bin H; Jie G; Guo-Xin M; Yan-Hong J; Li-Xin X
Respir Care; 2011 Nov; 56(11):1837-9. PubMed ID: 21605482
[TBL] [Abstract][Full Text] [Related]
6. An immunocompromised patient with necrotic chin lesions.
Khan FA; Vinjamuri M; Sarwari A
Clin Infect Dis; 2006 Jan; 42(2):242-3, 296-7. PubMed ID: 16363069
[No Abstract] [Full Text] [Related]
7. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
Chamilos G; Lewis RE; Kontoyiannis DP
Clin Infect Dis; 2008 Aug; 47(4):503-9. PubMed ID: 18611163
[TBL] [Abstract][Full Text] [Related]
8. A 19-year-old man with progressive lung infiltrates.
Tonelli AR; Olson EL
Cleve Clin J Med; 2009 Nov; 76(11):635-8. PubMed ID: 19884291
[No Abstract] [Full Text] [Related]
9. [Zygomycosis following liver transplantation in adults: report of three cases].
Brandão A; Marroni CA; Cerski CT; Gleisner AL; Zanotelli ML; Cantisani G
Rev Soc Bras Med Trop; 2003; 36(6):729-33. PubMed ID: 15049114
[TBL] [Abstract][Full Text] [Related]
10. Forty-one recent cases of invasive zygomycosis from a global clinical registry.
Rüping MJ; Heinz WJ; Kindo AJ; Rickerts V; Lass-Flörl C; Beisel C; Herbrecht R; Roth Y; Silling G; Ullmann AJ; Borchert K; Egerer G; Maertens J; Maschmeyer G; Simon A; Wattad M; Fischer G; Vehreschild JJ; Cornely OA
J Antimicrob Chemother; 2010 Feb; 65(2):296-302. PubMed ID: 20008047
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of cutaneous zygomycosis.
Visser DH; van den Berg YL; van Furth AM; Oomen MW; Schouten-van Meeteren AY; Pajkrt D; van den Bos C; van Well GT
Pediatr Infect Dis J; 2007 Dec; 26(12):1165-6. PubMed ID: 18043463
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies.
Valentini CG; Candoni A; Fianchi L; Posteraro B; Simeone E; Costa F; Sanguinetti M; Voso MT; Caira M; Fanin R; Pagano L
Mycoses; 2010 Jan; 53(1):89-92. PubMed ID: 19207832
[TBL] [Abstract][Full Text] [Related]
13. Invasive zygomycosis in transplant recipients.
Uçkay I; Chalandon Y; Sartoretti P; Rohner P; Berney T; Hadaya K; van Delden C
Clin Transplant; 2007; 21(4):577-82. PubMed ID: 17645724
[TBL] [Abstract][Full Text] [Related]
14. Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases.
Shoham S; Magill SS; Merz WG; Gonzalez C; Seibel N; Buchanan WL; Knudsen TA; Sarkisova TA; Walsh TJ
Med Mycol; 2010 May; 48(3):511-7. PubMed ID: 19824881
[TBL] [Abstract][Full Text] [Related]
15. Lipid formulations of amphotericin B as first-line treatment of zygomycosis.
Petrikkos GL
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():87-92. PubMed ID: 19754765
[TBL] [Abstract][Full Text] [Related]
16. Zygomycosis and diabetes mellitus.
Lanternier F; Lortholary O
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():21-5. PubMed ID: 19754752
[TBL] [Abstract][Full Text] [Related]
17. Posaconazole as first line treatment for disseminated zygomycosis.
Peel T; Daffy J; Thursky K; Stanley P; Buising K
Mycoses; 2008 Nov; 51(6):542-5. PubMed ID: 18422921
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary zygomycosis.
Pyrgos V; Shoham S; Walsh TJ
Semin Respir Crit Care Med; 2008 Apr; 29(2):111-20. PubMed ID: 18365993
[TBL] [Abstract][Full Text] [Related]
19. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
Cordonnier C; Bresnik M; Ebrahimi R
Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
[TBL] [Abstract][Full Text] [Related]
20. Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis.
Eisen DP; Robson J
Mycoses; 2004 Apr; 47(3-4):159-62. PubMed ID: 15078434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
